J THORAC ONCOL 润色咨询

Journal of Thoracic Oncology

出版年份：2006 年文章数：1357 投稿命中率： 开通期刊会员，数据随心看

出版周期：Monthly 自引率：6.1% 审稿周期： 开通期刊会员，数据随心看

前往期刊查询
期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=536257, encodeId=333353625ee9, content=想问问文章被接受后，offprints怎么买？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=255, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9b132018969, createdName=smilefeng9224, createdTime=Tue May 02 12:37:00 CST 2017, time=2017-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=532783, encodeId=ad00532e83b6, content=请问是不是投稿后每个作者要回复disclosure了才会进入下一步审稿？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=345, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bb7d1609316, createdName=littlestarstar, createdTime=Mon Feb 13 22:19:00 CST 2017, time=2017-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=525709, encodeId=e320525e09f3, content=接收个案报道吗？了解的回复下谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=311, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/18/138869a51881d5301c1c6d241373ddfa.jpg, createdBy=f89b1930658, createdName=耐看, createdTime=Tue Aug 09 23:53:00 CST 2016, time=2016-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=520119, encodeId=ac8252011950, content=今年接收了一篇简报，感觉还是杂志对于前沿很看重，对实验指导临床的内容感兴趣，审稿很严格，编辑和审稿人都提出了相应问题，审稿很快，修回后认真修改，很快就能得到回复, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=563, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5ace1663430, createdName=九命喵喵喵, createdTime=Fri Mar 11 22:45:00 CST 2016, time=2016-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=514933, encodeId=0a22514933c8, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：纠正，去年共27篇，今年到现在22篇，总共有望达到30篇, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=353, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Sun Aug 30 21:37:00 CST 2015, time=2015-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=514932, encodeId=d52a514932ab, content=审稿速度:1.0 | 投稿命中率:5.0<br>经验分享：楼下是牛人呀，这个杂志不好发。去年一年,中国人也就发22篇, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=421, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Sun Aug 30 21:35:00 CST 2015, time=2015-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=506471, encodeId=0bfe5064e172, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：7月22日用Email与编辑联系，想在journal of thoracic oncology发An unsolicited review,附文章。8月5日收到编辑Email，同意在线submission。8月7日成功提交，8月27日，审回，一个reviewer 认为很好，无需修改；另一个reviewer给出一些comments。9月27日review revised。9月29日，accept。本人和合作者都是第一次写review，但历时半年的写作，终于得到一份满意的结果。兴奋中！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=397, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1917110347, createdName=ruiruima, createdTime=Wed Oct 01 14:11:00 CST 2014, time=2014-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=504468, encodeId=15a450446869, content=审稿速度:3.0 | 投稿命中率:25.0<br>经验分享：涨的飞快 WCLC的官方杂志 不过差不多了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=448, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Jul 30 11:14:00 CST 2014, time=2014-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=502959, encodeId=53f850295902, content=秒据，理由是稿件很多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=411, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri May 16 22:22:00 CST 2014, time=2014-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=498133, encodeId=d1d049813389, content=我投过一篇纯临床的文章，一天就被拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=410, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Mon Jul 29 10:57:00 CST 2013, time=2013-07-29, status=1, ipAttribution=)]
    2017-05-02 smilefeng9224

    想问问文章被接受后，offprints怎么买？

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=536257, encodeId=333353625ee9, content=想问问文章被接受后，offprints怎么买？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=255, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9b132018969, createdName=smilefeng9224, createdTime=Tue May 02 12:37:00 CST 2017, time=2017-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=532783, encodeId=ad00532e83b6, content=请问是不是投稿后每个作者要回复disclosure了才会进入下一步审稿？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=345, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bb7d1609316, createdName=littlestarstar, createdTime=Mon Feb 13 22:19:00 CST 2017, time=2017-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=525709, encodeId=e320525e09f3, content=接收个案报道吗？了解的回复下谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=311, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/18/138869a51881d5301c1c6d241373ddfa.jpg, createdBy=f89b1930658, createdName=耐看, createdTime=Tue Aug 09 23:53:00 CST 2016, time=2016-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=520119, encodeId=ac8252011950, content=今年接收了一篇简报，感觉还是杂志对于前沿很看重，对实验指导临床的内容感兴趣，审稿很严格，编辑和审稿人都提出了相应问题，审稿很快，修回后认真修改，很快就能得到回复, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=563, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5ace1663430, createdName=九命喵喵喵, createdTime=Fri Mar 11 22:45:00 CST 2016, time=2016-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=514933, encodeId=0a22514933c8, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：纠正，去年共27篇，今年到现在22篇，总共有望达到30篇, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=353, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Sun Aug 30 21:37:00 CST 2015, time=2015-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=514932, encodeId=d52a514932ab, content=审稿速度:1.0 | 投稿命中率:5.0<br>经验分享：楼下是牛人呀，这个杂志不好发。去年一年,中国人也就发22篇, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=421, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Sun Aug 30 21:35:00 CST 2015, time=2015-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=506471, encodeId=0bfe5064e172, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：7月22日用Email与编辑联系，想在journal of thoracic oncology发An unsolicited review,附文章。8月5日收到编辑Email，同意在线submission。8月7日成功提交，8月27日，审回，一个reviewer 认为很好，无需修改；另一个reviewer给出一些comments。9月27日review revised。9月29日，accept。本人和合作者都是第一次写review，但历时半年的写作，终于得到一份满意的结果。兴奋中！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=397, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1917110347, createdName=ruiruima, createdTime=Wed Oct 01 14:11:00 CST 2014, time=2014-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=504468, encodeId=15a450446869, content=审稿速度:3.0 | 投稿命中率:25.0<br>经验分享：涨的飞快 WCLC的官方杂志 不过差不多了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=448, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Jul 30 11:14:00 CST 2014, time=2014-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=502959, encodeId=53f850295902, content=秒据，理由是稿件很多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=411, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri May 16 22:22:00 CST 2014, time=2014-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=498133, encodeId=d1d049813389, content=我投过一篇纯临床的文章，一天就被拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=410, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Mon Jul 29 10:57:00 CST 2013, time=2013-07-29, status=1, ipAttribution=)]
    2017-02-13 littlestarstar

    请问是不是投稿后每个作者要回复disclosure了才会进入下一步审稿？

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=536257, encodeId=333353625ee9, content=想问问文章被接受后，offprints怎么买？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=255, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9b132018969, createdName=smilefeng9224, createdTime=Tue May 02 12:37:00 CST 2017, time=2017-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=532783, encodeId=ad00532e83b6, content=请问是不是投稿后每个作者要回复disclosure了才会进入下一步审稿？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=345, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bb7d1609316, createdName=littlestarstar, createdTime=Mon Feb 13 22:19:00 CST 2017, time=2017-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=525709, encodeId=e320525e09f3, content=接收个案报道吗？了解的回复下谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=311, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/18/138869a51881d5301c1c6d241373ddfa.jpg, createdBy=f89b1930658, createdName=耐看, createdTime=Tue Aug 09 23:53:00 CST 2016, time=2016-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=520119, encodeId=ac8252011950, content=今年接收了一篇简报，感觉还是杂志对于前沿很看重，对实验指导临床的内容感兴趣，审稿很严格，编辑和审稿人都提出了相应问题，审稿很快，修回后认真修改，很快就能得到回复, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=563, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5ace1663430, createdName=九命喵喵喵, createdTime=Fri Mar 11 22:45:00 CST 2016, time=2016-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=514933, encodeId=0a22514933c8, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：纠正，去年共27篇，今年到现在22篇，总共有望达到30篇, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=353, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Sun Aug 30 21:37:00 CST 2015, time=2015-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=514932, encodeId=d52a514932ab, content=审稿速度:1.0 | 投稿命中率:5.0<br>经验分享：楼下是牛人呀，这个杂志不好发。去年一年,中国人也就发22篇, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=421, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Sun Aug 30 21:35:00 CST 2015, time=2015-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=506471, encodeId=0bfe5064e172, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：7月22日用Email与编辑联系，想在journal of thoracic oncology发An unsolicited review,附文章。8月5日收到编辑Email，同意在线submission。8月7日成功提交，8月27日，审回，一个reviewer 认为很好，无需修改；另一个reviewer给出一些comments。9月27日review revised。9月29日，accept。本人和合作者都是第一次写review，但历时半年的写作，终于得到一份满意的结果。兴奋中！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=397, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1917110347, createdName=ruiruima, createdTime=Wed Oct 01 14:11:00 CST 2014, time=2014-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=504468, encodeId=15a450446869, content=审稿速度:3.0 | 投稿命中率:25.0<br>经验分享：涨的飞快 WCLC的官方杂志 不过差不多了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=448, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Jul 30 11:14:00 CST 2014, time=2014-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=502959, encodeId=53f850295902, content=秒据，理由是稿件很多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=411, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri May 16 22:22:00 CST 2014, time=2014-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=498133, encodeId=d1d049813389, content=我投过一篇纯临床的文章，一天就被拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=410, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Mon Jul 29 10:57:00 CST 2013, time=2013-07-29, status=1, ipAttribution=)]
    2016-08-09 耐看

    接收个案报道吗？了解的回复下谢谢

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=536257, encodeId=333353625ee9, content=想问问文章被接受后，offprints怎么买？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=255, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9b132018969, createdName=smilefeng9224, createdTime=Tue May 02 12:37:00 CST 2017, time=2017-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=532783, encodeId=ad00532e83b6, content=请问是不是投稿后每个作者要回复disclosure了才会进入下一步审稿？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=345, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bb7d1609316, createdName=littlestarstar, createdTime=Mon Feb 13 22:19:00 CST 2017, time=2017-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=525709, encodeId=e320525e09f3, content=接收个案报道吗？了解的回复下谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=311, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/18/138869a51881d5301c1c6d241373ddfa.jpg, createdBy=f89b1930658, createdName=耐看, createdTime=Tue Aug 09 23:53:00 CST 2016, time=2016-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=520119, encodeId=ac8252011950, content=今年接收了一篇简报，感觉还是杂志对于前沿很看重，对实验指导临床的内容感兴趣，审稿很严格，编辑和审稿人都提出了相应问题，审稿很快，修回后认真修改，很快就能得到回复, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=563, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5ace1663430, createdName=九命喵喵喵, createdTime=Fri Mar 11 22:45:00 CST 2016, time=2016-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=514933, encodeId=0a22514933c8, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：纠正，去年共27篇，今年到现在22篇，总共有望达到30篇, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=353, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Sun Aug 30 21:37:00 CST 2015, time=2015-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=514932, encodeId=d52a514932ab, content=审稿速度:1.0 | 投稿命中率:5.0<br>经验分享：楼下是牛人呀，这个杂志不好发。去年一年,中国人也就发22篇, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=421, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Sun Aug 30 21:35:00 CST 2015, time=2015-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=506471, encodeId=0bfe5064e172, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：7月22日用Email与编辑联系，想在journal of thoracic oncology发An unsolicited review,附文章。8月5日收到编辑Email，同意在线submission。8月7日成功提交，8月27日，审回，一个reviewer 认为很好，无需修改；另一个reviewer给出一些comments。9月27日review revised。9月29日，accept。本人和合作者都是第一次写review，但历时半年的写作，终于得到一份满意的结果。兴奋中！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=397, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1917110347, createdName=ruiruima, createdTime=Wed Oct 01 14:11:00 CST 2014, time=2014-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=504468, encodeId=15a450446869, content=审稿速度:3.0 | 投稿命中率:25.0<br>经验分享：涨的飞快 WCLC的官方杂志 不过差不多了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=448, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Jul 30 11:14:00 CST 2014, time=2014-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=502959, encodeId=53f850295902, content=秒据，理由是稿件很多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=411, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri May 16 22:22:00 CST 2014, time=2014-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=498133, encodeId=d1d049813389, content=我投过一篇纯临床的文章，一天就被拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=410, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Mon Jul 29 10:57:00 CST 2013, time=2013-07-29, status=1, ipAttribution=)]
    2016-03-11 九命喵喵喵

    今年接收了一篇简报，感觉还是杂志对于前沿很看重，对实验指导临床的内容感兴趣，审稿很严格，编辑和审稿人都提出了相应问题，审稿很快，修回后认真修改，很快就能得到回复

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=536257, encodeId=333353625ee9, content=想问问文章被接受后，offprints怎么买？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=255, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9b132018969, createdName=smilefeng9224, createdTime=Tue May 02 12:37:00 CST 2017, time=2017-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=532783, encodeId=ad00532e83b6, content=请问是不是投稿后每个作者要回复disclosure了才会进入下一步审稿？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=345, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bb7d1609316, createdName=littlestarstar, createdTime=Mon Feb 13 22:19:00 CST 2017, time=2017-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=525709, encodeId=e320525e09f3, content=接收个案报道吗？了解的回复下谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=311, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/18/138869a51881d5301c1c6d241373ddfa.jpg, createdBy=f89b1930658, createdName=耐看, createdTime=Tue Aug 09 23:53:00 CST 2016, time=2016-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=520119, encodeId=ac8252011950, content=今年接收了一篇简报，感觉还是杂志对于前沿很看重，对实验指导临床的内容感兴趣，审稿很严格，编辑和审稿人都提出了相应问题，审稿很快，修回后认真修改，很快就能得到回复, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=563, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5ace1663430, createdName=九命喵喵喵, createdTime=Fri Mar 11 22:45:00 CST 2016, time=2016-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=514933, encodeId=0a22514933c8, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：纠正，去年共27篇，今年到现在22篇，总共有望达到30篇, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=353, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Sun Aug 30 21:37:00 CST 2015, time=2015-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=514932, encodeId=d52a514932ab, content=审稿速度:1.0 | 投稿命中率:5.0<br>经验分享：楼下是牛人呀，这个杂志不好发。去年一年,中国人也就发22篇, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=421, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Sun Aug 30 21:35:00 CST 2015, time=2015-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=506471, encodeId=0bfe5064e172, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：7月22日用Email与编辑联系，想在journal of thoracic oncology发An unsolicited review,附文章。8月5日收到编辑Email，同意在线submission。8月7日成功提交，8月27日，审回，一个reviewer 认为很好，无需修改；另一个reviewer给出一些comments。9月27日review revised。9月29日，accept。本人和合作者都是第一次写review，但历时半年的写作，终于得到一份满意的结果。兴奋中！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=397, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1917110347, createdName=ruiruima, createdTime=Wed Oct 01 14:11:00 CST 2014, time=2014-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=504468, encodeId=15a450446869, content=审稿速度:3.0 | 投稿命中率:25.0<br>经验分享：涨的飞快 WCLC的官方杂志 不过差不多了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=448, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Jul 30 11:14:00 CST 2014, time=2014-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=502959, encodeId=53f850295902, content=秒据，理由是稿件很多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=411, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri May 16 22:22:00 CST 2014, time=2014-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=498133, encodeId=d1d049813389, content=我投过一篇纯临床的文章，一天就被拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=410, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Mon Jul 29 10:57:00 CST 2013, time=2013-07-29, status=1, ipAttribution=)]
    2015-08-30 lovetcm

    审稿速度:1.0 | 投稿命中率:25.0
    经验分享：纠正，去年共27篇，今年到现在22篇，总共有望达到30篇

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=536257, encodeId=333353625ee9, content=想问问文章被接受后，offprints怎么买？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=255, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9b132018969, createdName=smilefeng9224, createdTime=Tue May 02 12:37:00 CST 2017, time=2017-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=532783, encodeId=ad00532e83b6, content=请问是不是投稿后每个作者要回复disclosure了才会进入下一步审稿？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=345, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bb7d1609316, createdName=littlestarstar, createdTime=Mon Feb 13 22:19:00 CST 2017, time=2017-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=525709, encodeId=e320525e09f3, content=接收个案报道吗？了解的回复下谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=311, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/18/138869a51881d5301c1c6d241373ddfa.jpg, createdBy=f89b1930658, createdName=耐看, createdTime=Tue Aug 09 23:53:00 CST 2016, time=2016-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=520119, encodeId=ac8252011950, content=今年接收了一篇简报，感觉还是杂志对于前沿很看重，对实验指导临床的内容感兴趣，审稿很严格，编辑和审稿人都提出了相应问题，审稿很快，修回后认真修改，很快就能得到回复, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=563, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5ace1663430, createdName=九命喵喵喵, createdTime=Fri Mar 11 22:45:00 CST 2016, time=2016-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=514933, encodeId=0a22514933c8, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：纠正，去年共27篇，今年到现在22篇，总共有望达到30篇, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=353, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Sun Aug 30 21:37:00 CST 2015, time=2015-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=514932, encodeId=d52a514932ab, content=审稿速度:1.0 | 投稿命中率:5.0<br>经验分享：楼下是牛人呀，这个杂志不好发。去年一年,中国人也就发22篇, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=421, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Sun Aug 30 21:35:00 CST 2015, time=2015-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=506471, encodeId=0bfe5064e172, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：7月22日用Email与编辑联系，想在journal of thoracic oncology发An unsolicited review,附文章。8月5日收到编辑Email，同意在线submission。8月7日成功提交，8月27日，审回，一个reviewer 认为很好，无需修改；另一个reviewer给出一些comments。9月27日review revised。9月29日，accept。本人和合作者都是第一次写review，但历时半年的写作，终于得到一份满意的结果。兴奋中！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=397, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1917110347, createdName=ruiruima, createdTime=Wed Oct 01 14:11:00 CST 2014, time=2014-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=504468, encodeId=15a450446869, content=审稿速度:3.0 | 投稿命中率:25.0<br>经验分享：涨的飞快 WCLC的官方杂志 不过差不多了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=448, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Jul 30 11:14:00 CST 2014, time=2014-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=502959, encodeId=53f850295902, content=秒据，理由是稿件很多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=411, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri May 16 22:22:00 CST 2014, time=2014-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=498133, encodeId=d1d049813389, content=我投过一篇纯临床的文章，一天就被拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=410, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Mon Jul 29 10:57:00 CST 2013, time=2013-07-29, status=1, ipAttribution=)]
    2015-08-30 lovetcm

    审稿速度:1.0 | 投稿命中率:5.0
    经验分享：楼下是牛人呀，这个杂志不好发。去年一年,中国人也就发22篇

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=536257, encodeId=333353625ee9, content=想问问文章被接受后，offprints怎么买？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=255, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9b132018969, createdName=smilefeng9224, createdTime=Tue May 02 12:37:00 CST 2017, time=2017-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=532783, encodeId=ad00532e83b6, content=请问是不是投稿后每个作者要回复disclosure了才会进入下一步审稿？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=345, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bb7d1609316, createdName=littlestarstar, createdTime=Mon Feb 13 22:19:00 CST 2017, time=2017-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=525709, encodeId=e320525e09f3, content=接收个案报道吗？了解的回复下谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=311, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/18/138869a51881d5301c1c6d241373ddfa.jpg, createdBy=f89b1930658, createdName=耐看, createdTime=Tue Aug 09 23:53:00 CST 2016, time=2016-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=520119, encodeId=ac8252011950, content=今年接收了一篇简报，感觉还是杂志对于前沿很看重，对实验指导临床的内容感兴趣，审稿很严格，编辑和审稿人都提出了相应问题，审稿很快，修回后认真修改，很快就能得到回复, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=563, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5ace1663430, createdName=九命喵喵喵, createdTime=Fri Mar 11 22:45:00 CST 2016, time=2016-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=514933, encodeId=0a22514933c8, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：纠正，去年共27篇，今年到现在22篇，总共有望达到30篇, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=353, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Sun Aug 30 21:37:00 CST 2015, time=2015-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=514932, encodeId=d52a514932ab, content=审稿速度:1.0 | 投稿命中率:5.0<br>经验分享：楼下是牛人呀，这个杂志不好发。去年一年,中国人也就发22篇, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=421, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Sun Aug 30 21:35:00 CST 2015, time=2015-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=506471, encodeId=0bfe5064e172, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：7月22日用Email与编辑联系，想在journal of thoracic oncology发An unsolicited review,附文章。8月5日收到编辑Email，同意在线submission。8月7日成功提交，8月27日，审回，一个reviewer 认为很好，无需修改；另一个reviewer给出一些comments。9月27日review revised。9月29日，accept。本人和合作者都是第一次写review，但历时半年的写作，终于得到一份满意的结果。兴奋中！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=397, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1917110347, createdName=ruiruima, createdTime=Wed Oct 01 14:11:00 CST 2014, time=2014-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=504468, encodeId=15a450446869, content=审稿速度:3.0 | 投稿命中率:25.0<br>经验分享：涨的飞快 WCLC的官方杂志 不过差不多了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=448, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Jul 30 11:14:00 CST 2014, time=2014-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=502959, encodeId=53f850295902, content=秒据，理由是稿件很多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=411, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri May 16 22:22:00 CST 2014, time=2014-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=498133, encodeId=d1d049813389, content=我投过一篇纯临床的文章，一天就被拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=410, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Mon Jul 29 10:57:00 CST 2013, time=2013-07-29, status=1, ipAttribution=)]
    2014-10-01 ruiruima

    审稿速度:1.0 | 投稿命中率:50.0
    经验分享：7月22日用Email与编辑联系，想在journal of thoracic oncology发An unsolicited review,附文章。8月5日收到编辑Email，同意在线submission。8月7日成功提交，8月27日，审回，一个reviewer 认为很好，无需修改；另一个reviewer给出一些comments。9月27日review revised。9月29日，accept。本人和合作者都是第一次写review，但历时半年的写作，终于得到一份满意的结果。兴奋中！

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=536257, encodeId=333353625ee9, content=想问问文章被接受后，offprints怎么买？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=255, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9b132018969, createdName=smilefeng9224, createdTime=Tue May 02 12:37:00 CST 2017, time=2017-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=532783, encodeId=ad00532e83b6, content=请问是不是投稿后每个作者要回复disclosure了才会进入下一步审稿？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=345, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bb7d1609316, createdName=littlestarstar, createdTime=Mon Feb 13 22:19:00 CST 2017, time=2017-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=525709, encodeId=e320525e09f3, content=接收个案报道吗？了解的回复下谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=311, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/18/138869a51881d5301c1c6d241373ddfa.jpg, createdBy=f89b1930658, createdName=耐看, createdTime=Tue Aug 09 23:53:00 CST 2016, time=2016-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=520119, encodeId=ac8252011950, content=今年接收了一篇简报，感觉还是杂志对于前沿很看重，对实验指导临床的内容感兴趣，审稿很严格，编辑和审稿人都提出了相应问题，审稿很快，修回后认真修改，很快就能得到回复, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=563, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5ace1663430, createdName=九命喵喵喵, createdTime=Fri Mar 11 22:45:00 CST 2016, time=2016-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=514933, encodeId=0a22514933c8, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：纠正，去年共27篇，今年到现在22篇，总共有望达到30篇, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=353, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Sun Aug 30 21:37:00 CST 2015, time=2015-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=514932, encodeId=d52a514932ab, content=审稿速度:1.0 | 投稿命中率:5.0<br>经验分享：楼下是牛人呀，这个杂志不好发。去年一年,中国人也就发22篇, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=421, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Sun Aug 30 21:35:00 CST 2015, time=2015-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=506471, encodeId=0bfe5064e172, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：7月22日用Email与编辑联系，想在journal of thoracic oncology发An unsolicited review,附文章。8月5日收到编辑Email，同意在线submission。8月7日成功提交，8月27日，审回，一个reviewer 认为很好，无需修改；另一个reviewer给出一些comments。9月27日review revised。9月29日，accept。本人和合作者都是第一次写review，但历时半年的写作，终于得到一份满意的结果。兴奋中！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=397, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1917110347, createdName=ruiruima, createdTime=Wed Oct 01 14:11:00 CST 2014, time=2014-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=504468, encodeId=15a450446869, content=审稿速度:3.0 | 投稿命中率:25.0<br>经验分享：涨的飞快 WCLC的官方杂志 不过差不多了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=448, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Jul 30 11:14:00 CST 2014, time=2014-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=502959, encodeId=53f850295902, content=秒据，理由是稿件很多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=411, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri May 16 22:22:00 CST 2014, time=2014-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=498133, encodeId=d1d049813389, content=我投过一篇纯临床的文章，一天就被拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=410, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Mon Jul 29 10:57:00 CST 2013, time=2013-07-29, status=1, ipAttribution=)]
    2014-07-30 匿名用户

    审稿速度:3.0 | 投稿命中率:25.0
    经验分享：涨的飞快 WCLC的官方杂志 不过差不多了

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=536257, encodeId=333353625ee9, content=想问问文章被接受后，offprints怎么买？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=255, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9b132018969, createdName=smilefeng9224, createdTime=Tue May 02 12:37:00 CST 2017, time=2017-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=532783, encodeId=ad00532e83b6, content=请问是不是投稿后每个作者要回复disclosure了才会进入下一步审稿？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=345, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bb7d1609316, createdName=littlestarstar, createdTime=Mon Feb 13 22:19:00 CST 2017, time=2017-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=525709, encodeId=e320525e09f3, content=接收个案报道吗？了解的回复下谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=311, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/18/138869a51881d5301c1c6d241373ddfa.jpg, createdBy=f89b1930658, createdName=耐看, createdTime=Tue Aug 09 23:53:00 CST 2016, time=2016-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=520119, encodeId=ac8252011950, content=今年接收了一篇简报，感觉还是杂志对于前沿很看重，对实验指导临床的内容感兴趣，审稿很严格，编辑和审稿人都提出了相应问题，审稿很快，修回后认真修改，很快就能得到回复, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=563, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5ace1663430, createdName=九命喵喵喵, createdTime=Fri Mar 11 22:45:00 CST 2016, time=2016-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=514933, encodeId=0a22514933c8, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：纠正，去年共27篇，今年到现在22篇，总共有望达到30篇, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=353, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Sun Aug 30 21:37:00 CST 2015, time=2015-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=514932, encodeId=d52a514932ab, content=审稿速度:1.0 | 投稿命中率:5.0<br>经验分享：楼下是牛人呀，这个杂志不好发。去年一年,中国人也就发22篇, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=421, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Sun Aug 30 21:35:00 CST 2015, time=2015-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=506471, encodeId=0bfe5064e172, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：7月22日用Email与编辑联系，想在journal of thoracic oncology发An unsolicited review,附文章。8月5日收到编辑Email，同意在线submission。8月7日成功提交，8月27日，审回，一个reviewer 认为很好，无需修改；另一个reviewer给出一些comments。9月27日review revised。9月29日，accept。本人和合作者都是第一次写review，但历时半年的写作，终于得到一份满意的结果。兴奋中！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=397, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1917110347, createdName=ruiruima, createdTime=Wed Oct 01 14:11:00 CST 2014, time=2014-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=504468, encodeId=15a450446869, content=审稿速度:3.0 | 投稿命中率:25.0<br>经验分享：涨的飞快 WCLC的官方杂志 不过差不多了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=448, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Jul 30 11:14:00 CST 2014, time=2014-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=502959, encodeId=53f850295902, content=秒据，理由是稿件很多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=411, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri May 16 22:22:00 CST 2014, time=2014-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=498133, encodeId=d1d049813389, content=我投过一篇纯临床的文章，一天就被拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=410, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Mon Jul 29 10:57:00 CST 2013, time=2013-07-29, status=1, ipAttribution=)]
    2014-05-16 匿名用户

    秒据，理由是稿件很多

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=536257, encodeId=333353625ee9, content=想问问文章被接受后，offprints怎么买？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=255, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9b132018969, createdName=smilefeng9224, createdTime=Tue May 02 12:37:00 CST 2017, time=2017-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=532783, encodeId=ad00532e83b6, content=请问是不是投稿后每个作者要回复disclosure了才会进入下一步审稿？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=345, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bb7d1609316, createdName=littlestarstar, createdTime=Mon Feb 13 22:19:00 CST 2017, time=2017-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=525709, encodeId=e320525e09f3, content=接收个案报道吗？了解的回复下谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=311, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/18/138869a51881d5301c1c6d241373ddfa.jpg, createdBy=f89b1930658, createdName=耐看, createdTime=Tue Aug 09 23:53:00 CST 2016, time=2016-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=520119, encodeId=ac8252011950, content=今年接收了一篇简报，感觉还是杂志对于前沿很看重，对实验指导临床的内容感兴趣，审稿很严格，编辑和审稿人都提出了相应问题，审稿很快，修回后认真修改，很快就能得到回复, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=563, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5ace1663430, createdName=九命喵喵喵, createdTime=Fri Mar 11 22:45:00 CST 2016, time=2016-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=514933, encodeId=0a22514933c8, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：纠正，去年共27篇，今年到现在22篇，总共有望达到30篇, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=353, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Sun Aug 30 21:37:00 CST 2015, time=2015-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=514932, encodeId=d52a514932ab, content=审稿速度:1.0 | 投稿命中率:5.0<br>经验分享：楼下是牛人呀，这个杂志不好发。去年一年,中国人也就发22篇, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=421, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Sun Aug 30 21:35:00 CST 2015, time=2015-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=506471, encodeId=0bfe5064e172, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：7月22日用Email与编辑联系，想在journal of thoracic oncology发An unsolicited review,附文章。8月5日收到编辑Email，同意在线submission。8月7日成功提交，8月27日，审回，一个reviewer 认为很好，无需修改；另一个reviewer给出一些comments。9月27日review revised。9月29日，accept。本人和合作者都是第一次写review，但历时半年的写作，终于得到一份满意的结果。兴奋中！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=397, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1917110347, createdName=ruiruima, createdTime=Wed Oct 01 14:11:00 CST 2014, time=2014-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=504468, encodeId=15a450446869, content=审稿速度:3.0 | 投稿命中率:25.0<br>经验分享：涨的飞快 WCLC的官方杂志 不过差不多了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=448, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Jul 30 11:14:00 CST 2014, time=2014-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=502959, encodeId=53f850295902, content=秒据，理由是稿件很多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=411, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri May 16 22:22:00 CST 2014, time=2014-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=498133, encodeId=d1d049813389, content=我投过一篇纯临床的文章，一天就被拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=410, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Mon Jul 29 10:57:00 CST 2013, time=2013-07-29, status=1, ipAttribution=)]
    2013-07-29 匿名用户

    我投过一篇纯临床的文章，一天就被拒了

    0

共43条页码: 3/5页10条/页
分享您的投稿经验，提升MI经验值，获取更多积分